Clinical Trial Update: DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of DS8201a (trastuzumab deruxtecan) in combination with pembrolizumab for locally advanced/metastatic breast cancer or non-small cell lung cancer;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Enhertu (trastuzumab deruxtecan) (trastuzumab deruxtecan)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Breast Cancer, Non-small Cell Lung Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING